Browsing Tag
Spur Therapeutics
1 post
How skeletal endpoints are becoming central to Gaucher disease innovation strategies
FLT201 data shifts focus to skeletal endpoints in Gaucher disease. Discover what this means for gene therapy strategy and market competition.